Therapeutic Potential of Kinkeliba (Combretum micranthum G. Don) Ethanolic Extract in Chronic DSS-Induced Colitis
Molecules · 23.04.2026 · 31 (9) · 1401
DOI: 10.3390/molecules31091401 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 23.04.2026. Verfasst von Ibrahima Mamadou Sall und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomic Pathology, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca, 400372 …. Hauptthemen laut MEDLINE: Plant Extracts, Combretum, Colitis, Ulcerative, Colitis. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Kinkeliba (Combretum micranthum G. Don), commonly used in West African traditional pharmacopeia for its anti-inflammatory and gastrointestinal properties, remains poorly studied regarding its potential role in the prevention or treatment of ulcerative colitis.
Objective
This study evaluated the therapeutic potential of the ethanolic extract of Combretum micranthum (EECM) in a murine model of chronic DSS-induced colitis.
Methods
Male C57BL/6 mice were subjected to three cycles of 1.5% DSS administration over nine weeks to induce chronic colitis. EECM was administered orally at 50, 100, or 200 mg/kg during the final week. Disease severity was evaluated using the Disease Activity Index (DAI), colon length, biochemical and hematological markers, along with histopathological and immunohistochemical assessment of colonic tissue.
Results
EECM treatment significantly improved clinical parameters and prevented colon shortening in chronic DSS-induced colitis. These improvements were associated with the restoration of serum biochemical and hematological profiles, along with reduced histopathological damage and preservation of colonic tissue architecture. Immunohistochemical analysis further demonstrated decreased CD3-positive T-lymphocyte infiltration in colonic tissue, suggesting modulation of local immune cell responses.
Conclusions
These findings highlight the therapeutic potential EECM in ulcerative colitis and support further investigations to elucidate its mechanisms of action and evaluate its efficacy in future translational studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomic Pathology, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca, 400372 Cluj-Napoca, Roumania.
- Laboratory of Plant Biotechnology and Ethnobotany, Faculty of Nature and Life Sciences, University of Bejaia, Bejaia 06000, Algeria.
- Department of Pathophysiology, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca, 400372 Cluj-Napoca, Romania.
ORCID-Profile: Ibrahima Mamadou Sall, Meriem Aziez, Dragoş Hodor, Alina Diana Haşaş, Mara-Georgiana Haralambie, Semzenisi Ecaterina, Alexandru-Flaviu Tăbăran
Zitieren
APA
Sall, I. M., Aziez, M., Hodor, D., Haşaş, A. D., Haralambie, M. G., Ecaterina, S., Hoța, A. T., & Tăbăran, A. F. (2026). Therapeutic Potential of Kinkeliba (Combretum micranthum G. Don) Ethanolic Extract in Chronic DSS-Induced Colitis. Molecules, 31(9), 1401. https://doi.org/10.3390/molecules31091401
Vancouver
Sall IM, Aziez M, Hodor D, Haşaş AD, Haralambie MG, Ecaterina S, et al. Therapeutic Potential of Kinkeliba (Combretum micranthum G. Don) Ethanolic Extract in Chronic DSS-Induced Colitis. Molecules. 2026;31(9):1401. doi:10.3390/molecules31091401
BibTeX
@article{Sall2026,
author = {Sall, Ibrahima Mamadou and Aziez, Meriem and Hodor, Dragoş and Haşaş, Alina Diana and Haralambie, Mara-Georgiana and Ecaterina, Semzenisi and Hoța, Alexia-Teodora and Tăbăran, Alexandru-Flaviu},
title = {Therapeutic Potential of Kinkeliba (Combretum micranthum G. Don) Ethanolic Extract in Chronic DSS-Induced Colitis},
journal = {Molecules},
year = {2026},
volume = {31},
number = {9},
pages = {1401},
doi = {10.3390/molecules31091401}
}
EUVIMED